Showing Results for: “exercise”

The American Diabetes Association® (ADA) will present the 2019 Outstanding Scientific Achievement Award (OSAA) to Sadaf Farooqi, MB, ChB (Hons), PhD. Dr. Farooqi will be recognized with this honor, which is given annually for research in diabetes that demonstrates particular independence of thought and originality, during the ADA’s 79th Scientific Sessions, June 7-11, 2019, at the Moscone Convention Center in San Francisco. She will deliver her OSAA Lecture, titled “ Obesity and the Biology of Weight Regulation,” during the National Scientific and Health Care Achievement Awards Presentation on

The American Diabetes Association® (ADA) will present the 2019 Banting Medal for Scientific Achievement, the ADA’s highest honor, to Stephen O’Rahilly, MD. The Banting Medal recognizes significant, long-term contributions to the understanding, treatment or prevention of diabetes. Dr. O’Rahilly will be recognized with this honor during the ADA’s 79th Scientific Sessions, June 7-11, 2019, at the Moscone Convention Center in San Francisco, and will deliver his Banting Medal Lecture, titled “ Treasure Your Exceptions—Studying Human Extreme Phenotypes to Illuminate Metabolic Health and Disease,”

The American Diabetes Association ® (ADA) and the European Association for the Study of Diabetes (EASD) announced today their new consensus update on management of hyperglycemia in type 2 diabetes. The update has been prepared by an international committee of experts that include John B. Buse, MD, PhD, (University of North Carolina School of Medicine, Chapel Hill, NC); Melanie J. Davies, CBE, MBChB, MD, FRCP, FRCGP, FMedSciat (Leicester Diabetes Centre, Leicester, UK); and their colleagues. It updates the previous 2018 and 2019 consensus reports, and like its predecessors, this new document

Roger lives with type 2 diabetes and resides in New Jersey. June 11, 2019 is the day that changed my life forever. This is the day that I was diagnosed with type 2 diabetes. However, as most diabetics, my journey started years earlier. This is my story about my journey to better health. I am 45 years old, married and have a 5-year-old daughter. Like most men my age I chose to ignore the warning signs over the years and lived my life like I didn’t have a care in the world. My wife and I were married at an early age and were both successful in our careers. I would visit the doctor when I was

Roger lives with type 2 diabetes and resides in New Jersey. June 11, 2019 is the day that changed my life forever. This is the day that I was diagnosed with type 2 diabetes. However, as most diabetics, my journey started years earlier. This is my story about my journey to better health. I am 45 years old, married and have a 5-year-old daughter. Like most men my age I chose to ignore the warning signs over the years and lived my life like I didn’t have a care in the world. My wife and I were married at an early age and were both successful in our careers. I would visit the Doctor when I was

Assiamira Ferrara, MD, PhD, has been selected to receive the American Diabetes Association’s® (ADA’s) 2019 Norbert Freinkel Award, given in memory of Norbert Freinkel, a dedicated investigator and industry thought leader. The Norbert Freinkel Award honors a researcher who has made outstanding contributions—including scientific publications and presentations—to the understanding and treatment of diabetes in pregnancy. Dr. Ferrara will be recognized with this honor during the ADA’s 79th Scientific Sessions, June 7–11, 2019, at the Moscone Convention Center in San Francisco. She will deliver the

The American Diabetes Association® (ADA) will present the 2019 Outstanding Educator in Diabetes Award to Virginia Valentine, APRN, BC-ADM, CDE, FAADE. This award recognizes a distinguished health professional who has made outstanding educational efforts in the field of diabetes and has demonstrated significant contributions to the understanding of diabetes education. Ms. Valentine will be recognized with this honor during the ADA’s 79th Scientific Sessions, June 7-11, 2019, at the Moscone Convention Center in San Francisco. She will deliver her Outstanding Educator in Diabetes Award Lecture

The American Diabetes Association® (ADA) will present the 2019 Outstanding Achievement in Clinical Diabetes Research Award to John B. Buse, MD, PhD. This award recognizes exceptional contributions in patient-oriented or clinical outcomes research that have had a significant impact on diabetes prevention and treatment. Dr. Buse will be recognized with this honor during the ADA’s 79th Scientific Sessions, June 7–11, 2019, at the Moscone Convention Center in San Francisco. Dr. Buse is the Verne S. Caviness Distinguished Professor, Chief of the Division of Endocrinology, Director of the Diabetes

Ten grants from the American Diabetes Association and the American Heart Association’s joint initiative aiming to decrease heart disease and stroke among people living with Type 2 diabetes. The American Diabetes Association ® and the American Heart Association ® have awarded grants to 10 community organizations to help people living with Type 2 diabetes lower their risk for cardiovascular diseases like heart attack, heart failure and stroke. The community grants are part of the leading health non-profits’ joint Know Diabetes by Heart ™ initiative which seeks to reduce cardiovascular events and

American Diabetes Association Symposium to Highlight Once Weekly Drug as Potential Treatment for Obesity Today, findings from SURMOUNT-1, the first investigational phase 3 trial evaluating the safety and efficacy of tirzepatide for the treatment of obesity, were announced, representing a new class of medicines being studied for the treatment of obesity. The trial was presented at a symposium at the 82nd Scientific Sessions of the American Diabetes Association ® (ADA) in New Orleans, LA, and simultaneously published in The New England Journal of Medicine. Obesity impacts 650 million people